Desmin and actin alterations in human muscles affected by delayed onset muscle soreness: a high resolution immunocytochemical study.
Lack of staining for desmin in muscles in animal models of eccentric exercise has been suggested to reflect disruption of the desmin intermediate filament network and proposed to cause disruption of the myofibrillar apparatus and deterioration of muscle fibers. In a recent study, we examined muscle biopsies from persons who had performed different eccentric exercise protocols, which induced delayed onset muscle soreness (DOMS). We were unable to verify that loss of staining for desmin was a feature of sore muscles. Nevertheless, we observed changes in the desmin cytoskeleton, but the meaning of the observations was not conclusive. In the present study, a high resolution immunocytochemical method was used to investigate the changes of desmin and actin in human muscles following a bout of eccentric exercise that lead to DOMS 2-3 days post-exercise. Biopsies were taken before exercise and 1 h and 2-3 and 7-8 days after exercise. Phalloidin, a ligand that labels filamentous actin, and anti-desmin antibodies were used to stain semithin (approximately 0.5 micro m) cryosections. At 1 h post-exercise, the staining of actin and desmin did not differ from the controls, whereas in biopsies taken 2-3 and 7-8 days after exercise, 12.5% (SD 5.8%) and 6.1% (SD 2.3%) fibers showed areas of increased staining for actin. Corresponding values for fibers with increased staining for both actin and desmin were 8.7% (SD 3.9%) and 11.4% (SD 4.6%), respectively. We suggest that the increased staining of actin and desmin reflects an increased synthesis of these proteins as part of an adaptation process following the unaccustomed eccentric exercise.
Yu
Ji-Guo
JG
Department of Integrative Medical Biology, Section for Anatomy, Umeå University, 901 87 Umeå, Sweden.
Thornell
Lars-Eric
LE
D000199:Actins / Q000032:analysis*; D000328:Adult; D003599:Cytoskeleton / Q000648:ultrastructure; D003893:Desmin / Q000032:analysis*; D015444:Exercise; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D024510:Muscle Development; D018763:Muscle Fatigue; D018482:Muscle, Skeletal / Q000648:ultrastructure*; D009210:Myofibrils / Q000648:ultrastructure; D010146:Pain; D012508:Sarcolemma / Q000648:ultrastructure
D000199:Actins; D003893:Desmin